Autopsy and Case Reports
Autopsy and Case Reports
Article / Clinical Case Report

Bullous systemic lupus erythematosus – a case report

Eduardo Messias Hirano Padrão; Lucas Faria Teixeira; Celina Wakisaka Maruta; Valéria Aoki; Aloisio Souza Felipe da Silva; Elizabeth In Myung Kim; Luciana Avena Smelli

Downloads: 3
Views: 376


Skin involvement in systemic lupus erythematosus (SLE) occurs in more than 75% of patients with this condition. Vesicles and blisters in lupus erythematosus (LE) may be present in SLE secondary to interface vacuolar changes in the epidermis, in discoid LE also secondary to vacuolar epidermal changes, and in bullous LE secondary to antibodies anti-collagen VII deposits with neutrophilic aggregates. In addition, blisters can occur due to the association of SLE with other autoimmune blistering diseases (e.g. bullous pemphigoid). BSLE is a rare blistering disease that mainly occurs in females (30–40 years old), and less frequently in children and adolescents. The most common presentation is rapid and widespread development of tense vesicles and bullae over erythematous macules or plaques. Preferential sites are: superior trunk, proximal superior limbs, and face (lips) with symmetrical distribution. Mucosal involvement is common on perioral, pharyngeal, laryngeal, and genital areas. The involvement of sun-exposed areas is not mandatory. The lesions usually progress with no scarring, but hypo or hyperchromia may be present. We report an 18-year-old female patient with blistering lesions at admission, who was diagnosed with BSLE. She was initially treated with systemic prednisone and hydroxychloroquine. Her condition evolved with relapsing lesions, which required the introduction of Dapsone. The authors emphasize the relevance of recognizing BSLE—a rare presentation of SLE—which may evolve with marked clinical presentation.


Lupus Erythematosus, Systemic, Blister, Dapsone, Diagnosis, Therapeutics


Watanabe T, Tsuchida T. Classification of lupus erythematosus based upon cutaneous manifestations. Dermatological, systemic and laboratory findings in 191 patients. Dermatology. 1995;190(4):277-83. 10.1159/000246716.7655105

Lourenço DM, Gomes RC, Aikawa NE, Campos LM, Romiti R, Silva CA. Childhood-onset bullous systemic lupus erythematosus. Lupus. 2014;23(13):1422-5. 10.1177/0961203314544187.25074872

Nico MMS, Lourenço SV. Multiple Blisters Along the Lip Vermilion are a Clue to Bullous Lupus Erythematosus. Acta Derm Venereol. 2012;92(4):404-5. 10.2340/00015555-1276.22293956

Bernard P, Vaillant L, Labeille B, et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Arch Dermatol. 1995;131(1):48-52. 10.1001/archderm.1995.01690130050009.7826096

Li AW, Weed JG, Stamey CR, Subtil A, Tomayko MM, Antaya RJ. Bullous systemic lupus erythematosus in a 6‐year‐old boy. Pediatr Dermatol. 2017;34(6):e313-6. 10.1111/pde.13258.28851077

Maggio MC, Corsello G, Prinzi E, Cimaz R. Systemic lupus erythematosus and bullous pemphigoid with dramatic response to dapsone. Am J Case Rep. 2017;18:317-9. 10.12659/AJCR.902351.28352068

Mahesh E, Madhyastha PR, Varma V, Gurudev KC, Gireesh MS, Bande SR. Unusual presentation of systemic lupus erythematosus. Saudi J Kidney Dis Transpl. 2017;28(3):653-6. 10.4103/1319-2442.206468.28540909

Juhász M, Rogge M, Chen M, Czernik A, Kim SJ, Geller L. Case of pediatric bullous systemic lupus erythematosus treated with intravenous immunoglobulin. Pediatr Dermatol. 2017;34(1):e54-6. 10.1111/pde.13015.27778386

Grabell DA, Matthews LA, Yancey KB, Chong BF. Detection of type VII collagen autoantibodies before the onset of bullous systemic lupus erythematosus. JAMA Dermatol. 2015;151(5):539-43. 10.1001/jamadermatol.2014.4409.25671758

Christodoulou G, Powell M, Nguyen V, Watters K, Jafarian F. An atypical case of bullous systemic lupus erythematosus in a 16‐year‐old boy. Pediatr Dermatol. 2014;31(6):e164-6. 10.1111/pde.12389.25040539

Liu KL, Shen J, Yang C, Chen YJ. Bullous systemic lupus erythematosus in a child responding to Dapsone. Pediatr Dermatol. 2014;31(4):e104-6. 10.1111/pde.12340.24846529

Burke KR, Green BP, Meyerle J. Bullous lupus in an 18‐year‐old. Pediatr Dermatol. 2011;28(4):483. 10.1111/j.1525-1470.2011.01502.x.21793895

Tincopa M, Puttgen KB, Sule S, Cohen BA, Gerstenblith MR. Bullous lupus: an unusual initial presentation of systemic lupus erythematosus in an adolescent girl. Pediatr Dermatol. 2010;27(4):373-6. 10.1111/j.1525-1470.2010.01179.x.20653856

Yogarajah M, Sivasambu B, Jaffe EA. Bullous systemic lupus erythematosus associated with esophagitis dissecans superficialis. Case Rep Rheumatol. 2015;2015:930683. 10.1155/2015/930683.25821624

Contestable JJ, Edhegard KD, Meyerle JH. Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment. Am J Clin Dermatol. 2014;15(6):517-24. 10.1007/s40257-014-0098-0.25358414

Burrows NP, Bhogal BS, Black MM, et al. Bullous eruption of systemic lupus erythematosus: a clinicopathological study of four cases. Br J Dermatol. 1993;128(3):332-8. 10.1111/j.1365-2133.1993.tb00180.x.8471519

Vassileva S. Bullous systemic lupus erythematosus. Clin Dermatol. 2004;22(2):129-38. 10.1016/j.clindermatol.2003.12.020.15234014

Shirahama S, Furukawa F, Yagi H, Tanaka T, Hashimoto T, Takigawa M. Bullous systemic lupus erythematosus: detection of antibodies against noncollagenous domain of type VII collagen. J Am Acad Dermatol. 1998;38(5 Suppl):844-8. 10.1016/S0190-9622(98)70472-4.9591800

Bain EE, Grover RK, Plunkett RW, Beutner EH. Detection of collagen VII autoantibodies to NC1 and NC2 domains of collagen VII by ELISA in suspected epidermolysis bullosa acquisita and bullous lupus erythematosus patients. J Dermatol Sci. 2012;65(2):155-6. 10.1016/j.jdermsci.2011.12.004.22225828

Camisa C, Sharma HM. Vesiculobullous systemic lupus erythematosus: report of two cases and a review of the literature. J Am Acad Dermatol. 1983;9(6):924-33. 10.1016/S0190-9622(83)70210-0.6358284

Camisa C, Grimwood RE. Indirect immunofluorescence in vesiculobullous eruption of systemic lupus erythematosus. J Invest Dermatol. 1986;86(5):606. 10.1111/1523-1747.ep12355583.3528314

Camisa C. Vesiculobullous systemic lupus erythematosus: a report of four cases. J Am Acad Dermatol. 1988;18(1 Pt 1):93-100. 10.1016/S0190-9622(88)70014-6.3279084

Piette EW, Werth VP. Dapsone in the management of the autoimmune bullous diseases. Dermatol Clin. 2011;29(4):561-4. 10.1016/j.det.2011.06.018.21924998

Hall RP, Lawley TJ, Smith HR, Katz SI. Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy. Ann Intern Med. 1982;97(2):165-70. 10.7326/0003-4819-97-2-165.7049027

Hans-Bittner NR, Bittner GC, Hans G Fo, Takita LC. Bullous systemic lupus erythematosus in a 10-year-old child. An Bras Dermatol. 2017;92(5 Suppl 1):37-9. 10.1590/abd1806-4841.20176074.29267441

Pehr K. Mycophenolate mofetil and erythromycin for bullous lupus erythematosus of childhood. J Cutan Med Surg. 2012;16(1):50-3. 10.1177/120347541201600110.22417996

Malcangi G, Brandozzi G, Giangiacomi M, Zampetti M, Danieli MG. Bullous SLE: response to methotrexate and relationship with disease activity. Lupus. 2003;12(1):63-6. 10.1191/0961203303lu241cr.12587829

Alsanafi S, Kovarik C, Mermelstein AL, Werth VP. Rituximab in the treatment of bullous systemic lupus erythematosus. J Clin Rheumatol. 2011;17(3):142-4. 10.1097/RHU.0b013e318214f30c.21441817




Publication date:

5c73e5220e8825946ada818c autopsy Articles
Links & Downloads

Autops Case Rep

Share this page
Page Sections